Dr Reddy's to Distribute Takeda's Qdenga Dengue Vaccine in India from 2027
Dr Reddy's Laboratories has signed a distribution agreement with Takeda Pharmaceutical to promote the Qdenga dengue vaccine in India, following its approval by India's drug regulator for individuals aged 4 to 60. Expected to be available in the first half of 2027, Qdenga is the country's first approved dengue vaccine, administered in two doses three months apart and usable without prior infection screening. Dengue remains a significant health concern, with over 232,000 cases and 233 deaths reported in India in 2024.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (59/100). Lens Score 47/100.
Outlets measured: moneycontrol, businessstandard, moneycontrol, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 18 Sept, 04:09 am. Other outlets followed.